Insulin-like growth factor-I receptor antagonism results in increased cytotoxicity of breast cancer cells to doxorubicin and taxol.

Source:http://linkedlifedata.com/resource/pubmed/id/11182049

Download in:

View as

General Info

PMID
11182049